Evidence map›Paper›PMID 32252783›Full record

ArticleRespiratory research2020

Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases.

Konstantinos P Exarchos, Athena Gogali, Agni Sioutkou, Christos Chronis, Sofia Peristeri, Konstantinos Kostikas

Abstract read
In one paragraph

Article in Respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Asthma management in the digital age.Frontiers in allergy · 2024
    Review
  14. Digital health in chronic obstructive pulmonary disease.Chronic diseases and translational medicine · 2023
    Review
  15. Article
  16. Article
  17. Respinos: A Portable Device for Remote Vital Signs Monitoring of COVID-19 Patients.IEEE transactions on biomedical circuits and systems · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Konstantinos P ExarchosRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece. kexarcho@gmail.com.
Athena GogaliRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
Agni SioutkouRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
Christos ChronisRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
Sofia PeristeriRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
Konstantinos KostikasRespiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic respiratory diseases constitute a considerable part in the practice of pulmonologists and primary care physicians; spirometry is integral for the diagnosis and monitoring of these diseases, yet remains underutilized. The Air Next spirometer (NuvoAir, Sweden) is a novel ultra-portable device that performs spirometric measurements connected to a smartphone or tablet via Bluetooth®.

methodsThe objective of this study was to assess the accuracy and validity of these measurements by comparing them with the ones obtained with a conventional desktop spirometer. Two hundred subjects were enrolled in the study with various spirometric patterns (50 patients with asthma, 50 with chronic obstructive pulmonary disease and 50 with interstitial lung disease) as well as 50 healthy individuals.

resultsFor the key spirometric parameters in the interpretation of spirometry, i.e. FEV

conclusionsOur results support the use of Air Next as a reliable spirometer for the screening and diagnosis of various spirometric patterns in clinical practice.

Indexed as

Cross-Sectional StudiesForced Expiratory VolumeHumansProspective StudiesReproducibility of ResultsRespiration DisordersSpirometrySweden

Identifiers

PMID32252783
PMCPMC7137268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.